about
Intracytoplasmic sperm injection: a novel selection method for sperm with normal frequency of chromosomal aneuploidiesMilder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization.Oocyte polarized light microscopy, assay of specific follicular fluid metabolites, and gene expression in cumulus cells as different approaches to predict fertilization efficiency after ICSI."Mild" vs. "long" protocol for controlled ovarian hyperstimulation in patients with expected poor ovarian responsiveness undergoing in vitro fertilization (IVF): a large prospective randomized trial.Effect of the method of conception and embryo transfer procedure on mid-gestation placenta and fetal development in an IVF mouse model.A critical review of bi-dimensional and three-dimensional ultrasound techniques to monitor follicle growth: do they help improving IVF outcome?Guanylate cyclase activity and sperm function.Recombinant versus highly-purified, urinary follicle-stimulating hormone (r-FSH vs. HP-uFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysis.Ovarian endometriomas and IVF: a retrospective case-control study.Ovarian sensitivity index is strongly related to circulating AMH and may be used to predict ovarian response to exogenous gonadotropins in IVFEfficacy and safety of late-start Corifollitropin-alfa administration for controlled ovarian hyperstimulation in IVF: a cohort, case-control study.Controlled Ovarian Stimulation with recombinant-FSH plus recombinant-LH vs. human Menopausal Gonadotropin based on the number of retrieved oocytes: results from a routine clinical practice in a real-life population.Outcome of in vitro fertilization in patients with proven poor ovarian responsiveness after early vs. mid-follicular LH exposure: a prospective, randomized, controlled studyEvaluation of equine oocyte developmental competence using polarized light microscopy.Polarized light microscopy-detectable structures of human oocytes and embryos are related to the likelihood of conception in IVF.A prospective, randomised, controlled clinical study on the assessment of tolerability and of clinical efficacy of Merional (hMG-IBSA) administered subcutaneously versus Merional administered intramuscularly in women undergoing multifollicular ovariAwareness of the effects of postponing motherhood among hospital gynecologists: is their knowledge sufficient to offer appropriate help to patients?Fertility in patients with multiple sclerosis: current knowledge and future perspectives.IVF results in patients with very low serum AMH are significantly affected by chronological ageImpact of oncostatic treatments for childhood malignancies (radiotherapy and chemotherapy) on uterine competence to pregnancy.Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics.IVF outcome is optimized when embryos are replaced between 5 and 15 mm from the fundal endometrial surface: a prospective analysis on 1184 IVF cycles.Laparoscopic conservative management of ureteral endometriosis: a survey of eighty patients submitted to ureterolysis.Endometrial adult/progenitor stem cells: pathogenetic theory and new antiangiogenic approach for endometriosis therapy.Fertility preservation in BRCA mutation carriers.Zona pellucida gene mRNA expression in human oocytes is related to oocyte maturity, zona inner layer retardance and fertilization competence.Angiogenic properties of endometrial mesenchymal stromal cells in endothelial co-culture: an in vitro model of endometriosis.Ovarian tissue cryopreservation in girls undergoing haematopoietic stem cell transplant: experience of a single centre.Empty follicle syndrome revisited: definition, incidence, aetiology, early diagnosis and treatment.Epithelial-mesenchymal transition of ovarian tumor cells induces an angiogenic monocyte cell population.Construction of an evidence-based integrated morphology cleavage embryo score for implantation potential of embryos scored and transferred on day 2 after oocyte retrieval.Steroid receptors in human spermatozoa.Cancer and fertility preservation: international recommendations from an expert meeting.The pentose phosphate pathway plays an essential role in supporting human sperm capacitation.Preserved insulin sensitivity and {beta}-cell activity, but decreased glucose effectiveness in normal-weight women with the polycystic ovary syndrome.Inducible nitric oxide synthase and heme oxygenase 1 are expressed in human cumulus cells and may be used as biomarkers of oocyte competence.IVF twins have similar obstetric and neonatal outcome as spontaneously conceived twins: a prospective follow-up study.Low-dose acetylsalicylic acid plus prednisolone as an adjuvant treatment in IVF: a prospective, randomized study.Fertility preservation program before ovarotoxic oncostatic treatments: role of the psychological support in managing emotional aspects.Is letrozole needed for controlled ovarian stimulation in patients with estrogen receptor-positive breast cancer?
P50
Q24169895-680554B4-D79D-46CF-B61F-C1D23394B1ABQ30399747-A94E08A5-DD42-4030-9115-7BC1CEDDE370Q33827655-9BEE1EEE-5019-4F43-AD48-8C6295C4B8EEQ33897168-DD1DC2A4-8DF0-4C42-8665-EAB166639F41Q34008052-D8327F4A-C096-4C35-91DD-5A7147246FB8Q34632570-81C6512F-4D10-4BFD-B808-93DCE9208AD3Q34803267-FD7DABEA-9D4C-493D-9E14-E8785F113901Q34997685-80CF2CBC-8C66-4B23-8AC1-B408A57ED001Q35105602-BA917180-C5D0-45D1-9294-3CBBDFB2D86FQ35184135-9DD98465-0E98-4CE2-8FA9-AAEADA468DFFQ35186866-5B84DB2D-E0B5-4A79-9BB6-B9C7010134C8Q35713241-5475CD7D-2BA5-4835-B9AC-F3BB38E6962EQ36295608-9494EF22-113F-401F-B8EA-A70157417909Q36304931-9A74ABA9-F4E0-4B8E-994D-41439F3C9FD2Q36381616-5BB33FE6-A8A8-4DCD-9DD3-B4A3318BAF15Q36409806-D1141B2A-92CB-46E5-BC8F-617E8BB06381Q36594307-F23910DF-2143-4B6C-8267-5263E1C31906Q36602753-D51C38DE-D9CC-4683-9C95-3EA123DFFFC2Q36910187-DBACEF97-BE82-41C7-9BB6-6D3E83DF624BQ37001692-229DA936-A940-4376-837E-940C7BF2832CQ37201103-7423A75E-F34A-4EF0-8B1A-2BDA1134B28FQ37401650-FCD70B58-DC94-4FB1-A240-38D5DCBEA1E9Q37405709-BA827885-80D6-411D-A5E7-095798D60B2AQ38137804-CDA46B4C-A478-4A2E-83BE-2406A24C73EFQ38782513-F216A77F-EBE7-4810-B694-1C11F562A287Q38958820-30F1DC94-73D8-4397-9942-53F13D28E74FQ38980517-0677A750-B923-4418-BDD3-E988CE59A279Q39008643-C6E44097-9944-4C75-B9F1-6683DBD596A3Q39360407-C55AAB5C-8AAA-4641-94E9-B2D28D34855DQ39836194-7612CF59-4316-4993-810C-84736A07CBC1Q40271383-0C77DB9A-8BDB-4199-B244-3B3F429A1074Q40634288-BB43F70A-8712-4900-ABCE-E8359B398041Q43106184-55FFEA0C-57AC-4AC6-934E-6F1567526581Q43264001-BFA13E64-1C6D-4E38-BF56-3E7E2FB53406Q45310721-4DC03ADC-D60A-4B2D-AA11-1DF601E8A199Q45326032-030A0AB6-3997-4FE2-94BC-2DD2D4A5D260Q46330510-60D7669D-5360-4E69-88D4-BD5F5C46243CQ46869654-9B0F1507-7741-4FF6-8759-4F27C1221D01Q47842488-68AFE019-BC03-4FF1-91ED-54726AE52E6FQ48618463-6FB1078B-57F4-4797-9D8D-E3BBDAFFA44E
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-5797-3722
@en
name
Alberto Revelli
@ast
Alberto Revelli
@en
Alberto Revelli
@es
Alberto Revelli
@nl
type
label
Alberto Revelli
@ast
Alberto Revelli
@en
Alberto Revelli
@es
Alberto Revelli
@nl
prefLabel
Alberto Revelli
@ast
Alberto Revelli
@en
Alberto Revelli
@es
Alberto Revelli
@nl
P106
P1153
7003917818
P21
P31
P496
0000-0002-5797-3722